On-Demand Videos From Novartis at the EuroPrevent Symposium

Published: 05 Feb 2018

  • Views:

    Views Icon 807
  • Likes:

    Heart Icon 0

The objective of the symposium is to educate on:

  • The role of inflammation in atherosclerosis.
  • That “residual inflammatory risk” is distinct from “residual cholesterol risk” and hence an independent risk factor for atherosclerosis.
  • How residual inflammatory risk can be easily diagnosed with available biomarkers – e.g., elevated hsCRP.
  • The role for tailored therapeutic strategies to reduce residual inflammatory risk to improve outcomes for post-MI patients.